{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:51:34Z","timestamp":1790718694217,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medical University in Bia\u0142ystok","award":["123-45748L and 134-45728L"],"award-info":[{"award-number":["123-45748L and 134-45728L"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.cyto.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T15:21:30Z","timestamp":1414596090000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Increased concentration of interferon lambda-3, interferon beta and interleukin-10 in the cerebrospinal fluid of patients with tick-borne encephalitis"],"prefix":"10.1016","volume":"71","author":[{"given":"Sambor","family":"Grygorczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Parczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moniuszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"\u015awierzbi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Kondrusik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Zajkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czupryna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Dunaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Boro\u0144-Kaczmarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Pancewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.10.001_b0005","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.011437-0","article-title":"Tick-borne encephalitis virus \u2013 a review of an emerging zoonosis","volume":"90","author":"Mansfield","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s150100050051","article-title":"Laboratory findings in tick-borne encephalitis \u2013 correlation with clinical outcome","volume":"28","author":"Kaiser","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.cyto.2014.10.001_b0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1365-2249.2003.02050.x","article-title":"Changes in immune parameters and their correction in human cases of tick-borne encephalitis","volume":"131","author":"Atrasheuskaya","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2014.10.001_b0020","unstructured":"Kindberg E, Mickien\u00e9 A, Vene S, \u00c5kerlind B, Haglund M, Lundkvist \u00c5, et al. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tick-borne encephalitis. In: Abstract book of 5th European Meeting on Viral Zoonoses. St Rapha\u00ebl, France, 2009 September 26\u201329; Abstract P-20: 76."},{"key":"10.1016\/j.cyto.2014.10.001_b0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiq082","article-title":"A functional toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection","volume":"203","author":"Kindberg","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2014.10.001_b0030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/657418","article-title":"Variability in the 2\u2032-5\u2032-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease","volume":"202","author":"Barkhash","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2014.10.001_b0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.10.017","article-title":"Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis","volume":"93","author":"Barkhash","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cyto.2014.10.001_b0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2009.04.026","article-title":"Mortality following peripheral infection with Tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses","volume":"390","author":"Hayasaka","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2014.10.001_b0045","doi-asserted-by":"crossref","first-page":"e1000321","DOI":"10.1371\/journal.ppat.1000321","article-title":"Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man","volume":"5","author":"Lim","year":"2009","journal-title":"PloS Pathog"},{"key":"10.1016\/j.cyto.2014.10.001_b0050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediated West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2014.10.001_b0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/00365549609049063","article-title":"Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology","volume":"28","author":"G\u00fcnther","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cyto.2014.10.001_b0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/13550280600848746","article-title":"Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue","volume":"12","author":"Gelpi","year":"2006","journal-title":"J Neurovirol"},{"key":"10.1016\/j.cyto.2014.10.001_b0065","first-page":"343","article-title":"Interferon-\u03b3 and cortisol levels in cerebrospinal fluid and its relationship to the etiology of aseptic meningoencephalitis","volume":"107","author":"Holub","year":"2006","journal-title":"Prague Med Rep"},{"key":"10.1016\/j.cyto.2014.10.001_b0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","article-title":"The two faces of interleukin 10 in human infectious diseases","volume":"6","author":"Mege","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cyto.2014.10.001_b0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(03)12709-2","article-title":"Interferon alfa-2a in Japanese encephalitis: a randomized double-blind placebo-controlled trial","volume":"361","author":"Solomon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2014.10.001_b0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1099\/vir.0.18654-0","article-title":"Role of type I and type II interferon responses in recovery from infection with an encephalic flavivirus","volume":"84","author":"Lobigs","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0085","first-page":"6029","article-title":"Tick-borne encephalitis is associated with low levels of interleukin-10 in cerebrospinal fluid","volume":"1","author":"G\u00fcnther","year":"2011","journal-title":"Infect Ecol Epidemiol"},{"key":"10.1016\/j.cyto.2014.10.001_b0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/00365549409011777","article-title":"Interferon-gamma in cerebrospinal fluid from patients with viral and bacterial meningitis","volume":"26","author":"Glim\u00e5ker","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cyto.2014.10.001_b0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2014.10.001_b0100","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.4049\/jimmunol.179.6.3434","article-title":"IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-\u03bb) genes","volume":"179","author":"\u00d6sterlund","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.10.001_b0105","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/gene.2008.87","article-title":"Human interferon-\u03bb3 is a potent member of the type III interferon family","volume":"10","author":"Dellgren","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.cyto.2014.10.001_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2005.04.003","article-title":"Biological activity of interleukins-28 and -29: comparison with type I interferons","volume":"31","author":"Meager","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.10.001_b0120","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"Doyle","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2014.10.001_b0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2893.2012.01649.x","article-title":"IL-28B (IFN-\u03bb3) and IFN-\u03b1 synergistically inhibit HCV replication","volume":"20","author":"Shindo","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cyto.2014.10.001_b0130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.10.001_b0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a novel interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2014.10.001_b0140","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile Wirus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0145","doi-asserted-by":"crossref","first-page":"847083","DOI":"10.1128\/JVI.00176-10","article-title":"Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles","volume":"84","author":"\u00d6verby","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"Hayes","year":"2006","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.cyto.2014.10.001_b0155","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL-28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"issue":"7265","key":"10.1016\/j.cyto.2014.10.001_b0160","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.10.001_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-1759(01)00349-0","article-title":"A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression","volume":"252","author":"Kristiansen","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cyto.2014.10.001_b0170","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.1128\/JVI.79.20.12893-12904.2005","article-title":"Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon","volume":"79","author":"Pr\u00e9haud","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0175","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/JVI.01167-06","article-title":"Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54 and ISG-56 in the central nervous system after infection with distinct viruses","volume":"81","author":"Wacher","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2014.10.001_b0180","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.micinf.2010.03.015","article-title":"Ixodes ricinus tick saliva modulates tick-borne encephalitis virus infection of dendritic cells","volume":"12","author":"Fialov\u00e1","year":"2010","journal-title":"Microbiol Infect"},{"key":"10.1016\/j.cyto.2014.10.001_b0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2478\/v10039-011-0033-z","article-title":"Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick-borne encephalitis (TBE)","volume":"56","author":"Zajkowska","year":"2011","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.cyto.2014.10.001_b0190","unstructured":"Kuivanen S, Kaukinen P, Silanp\u00e4\u00e4 M, Uzc\u00e1tegui de Castillo N, Vaheri A, Julkunen I, et al. Tick-borne encephalitis virus proteins prM and NS1 act as potent inhibitors of cytokine gene expression. In: Abstract book of 5th European meeting on viral zoonoses. St Rapha\u00ebl, France, 2009 September 26\u201329; Abstract P-23: 79."},{"key":"10.1016\/j.cyto.2014.10.001_b0195","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jvh.12082","article-title":"Relationship between IL-10 gene -1082A\/G and -592C\/A polymorphisms and the risk of hepatitis C infection: a meta-analysis","volume":"20","author":"Sun","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cyto.2014.10.001_b0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jhep.2013.04.007","article-title":"Treatment optimization and prediction of HCV clearance in patients with acute HCV infection","volume":"59","author":"Mangia","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2014.10.001_b0205","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S031716710005383X","article-title":"Calgary experience with West Nile virus neurological syndrome during the late summer of 2003","volume":"31","author":"Sayao","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.cyto.2014.10.001_b0210","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/423325","article-title":"Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study","volume":"190","author":"Rahal","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2014.10.001_b0215","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.23850","article-title":"ATACH study group. potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection","volume":"52","author":"Grebely","year":"2010","journal-title":"Hepatology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T04:57:44Z","timestamp":1538110664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614005419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1043466614005419"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.10.001","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased concentration of interferon lambda-3, interferon beta and interleukin-10 in the cerebrospinal fluid of patients with tick-borne encephalitis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}